{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:12:15Z","timestamp":1767136335967,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011649","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000}}],"reference-count":183,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011649.pub2","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T21:34:41Z","timestamp":1489095281000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of people with intermediate-stage hepatocellular carcinoma"],"prefix":"10.1002","author":[{"given":"Davide","family":"Roccarina","sequence":"additional","affiliation":[{"name":"Sheila Sherlock Liver Centre; Royal Free Hospital and the UCL Institute of Liver and Digestive Health; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avik","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Sheila Sherlock Liver Centre; Royal Free Hospital and the UCL Institute of Liver and Digestive Health; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"Sheila Sherlock Liver Centre; Royal Free Hospital and the UCL Institute of Liver and Digestive Health; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science; University College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"Sheila Sherlock Liver Centre; Royal Free Hospital and the UCL Institute of Liver and Digestive Health; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurinchi Selvan","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science; University College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"Journal of hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011649.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0168-8278(09)60069-6","article-title":"Efficacy and safety of sorafenib in patients with hepatocellular carcinoma (HCC): subanalysis of sharp trial based on Barcelona clinic liver cancer (BCLC) stage","volume":"50","author":"Bruix","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S852","DOI":"10.1016\/S0168-8278(15)31504-X","article-title":"Efficacy and safety of combined sequential treatment with RFA and sorafenib in patients with HCC in intermediate stage ineligible for TACE: a prospective randomized open study","volume":"62","author":"Stefano","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/annonc\/mdv344.45","article-title":"Efficacy and safety of combined sequential treatment with radiofrequency ablation and sorafenib in patients with hepatocellular carcinoma in intermediate stage ineligible for TACE: a prospective randomized open study","volume":"26","author":"Stefano","year":"2015","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0006|cit6","first-page":"S616","article-title":"Sorafenib plus transarterial chemoembolization with DC bead (DEB-TACE) for patients from Asian countries with intermediate-stage HCC: SPACE study results","volume":"7","author":"Han","year":"2013","journal-title":"Hepatology International"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2016.01.012","article-title":"Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: the SPACE trial","volume":"64","author":"Lencioni","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"Suppl 15","key":"10.1002\/14651858.CD011649.pub2-BIB0008|cit8","first-page":"26","article-title":"Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (SPACE)","volume":"28","author":"Lencioni","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365521.2014.1003397","article-title":"Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis","volume":"50","author":"Abdelaziz","year":"2015","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"19","key":"10.1002\/14651858.CD011649.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'etude et de traitement du carcinome hepatocellulaire","volume":"332","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD011649.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"Abstract: 4030","DOI":"10.1200\/jco.2010.28.15_suppl.4030","article-title":"A randomized phase II study of TSU-68 in patients (pts) with hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE)","volume":"28","author":"Arai","year":"2010","journal-title":"Journal of Clinical Oncology Conference"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1148\/radiology.197.3.7480761","article-title":"Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization","volume":"197","author":"Bartolozzi","year":"1995","journal-title":"Radiology"},{"issue":"39","key":"10.1002\/14651858.CD011649.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.3748\/wjg.v11.i39.6104","article-title":"Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma","volume":"11","author":"Becker","year":"2005","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.510270617","article-title":"Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution","volume":"27","author":"Bruix","year":"1998","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v8.i1.74","article-title":"High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma","volume":"8","author":"Chen","year":"2002","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000102901","article-title":"Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma","volume":"24","author":"Chen","year":"2007","journal-title":"Digestive Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0017|cit17","first-page":"305","article-title":"Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma","volume":"26","author":"Cheng","year":"2004","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"14","key":"10.1002\/14651858.CD011649.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.299.14.1669","article-title":"Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. (Retraction in: JAMA 2009; 301(18):1931)","volume":"299","author":"Cheng","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ijrobp.2014.08.011","article-title":"A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma","volume":"90","author":"Choi","year":"2014","journal-title":"International Journal of Radiation Oncology"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/jhep.2002.36824","article-title":"High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized controlled trial","volume":"36","author":"Chow","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"18","key":"10.1002\/14651858.CD011649.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.2009.640","article-title":"Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. (Retraction of: JAMA 2008; 299(14):1669-77)","volume":"301","author":"DeAngelis","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejca.2008.01.004","article-title":"Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients","volume":"44","author":"Doffoel","year":"2008","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MEG.0b013e32835d2c4f","article-title":"Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma","volume":"25","author":"El-Kady","year":"2013","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0024|cit24","first-page":"356","article-title":"Treatment of large hepatocellular carcinoma: comparison between techniques and long term results","volume":"108","author":"Ferrari","year":"2004","journal-title":"Radiologia Medica"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD011649.pub2-BIB0025|cit25","first-page":"S252","article-title":"Prospective, randomized study of coiling vs surefire infusion system in Y-90: clinical outcomes in HCC patients-subgroup analysis of safety and efficacy from the COSY trial","volume":"37","author":"Fischman","year":"2014","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2407-6-196","article-title":"Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma","volume":"6","author":"Gallo","year":"2006","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12072-009-9132-3","article-title":"A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma","volume":"3","author":"Gish","year":"2009","journal-title":"Hepatology International"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"Golfieri","year":"2014","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1016\/S0959-8049(16)31221-7","article-title":"Randomized phase 2\/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16\/SATURNE study): results of the phase II part","volume":"51","author":"Hebbar","year":"2015","journal-title":"European Journal of Cancer"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011649.pub2-BIB0030|cit30","first-page":"78","article-title":"Sorafenib improves survival in patients with hepatocellular carcinoma: results of a large multicenter, randomized, placebo-controlled phase III trial","volume":"31","author":"Hilgard","year":"2008","journal-title":"Onkologie"},{"issue":"21","key":"10.1002\/14651858.CD011649.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3748\/wjg.15.2638","article-title":"Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment","volume":"15","author":"Hou","year":"2009","journal-title":"World Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD011649.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/00365520310003048","article-title":"Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study","volume":"38","author":"Huo","year":"2003","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11547-012-0914-7","article-title":"Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE)","volume":"118","author":"Iezzi","year":"2013","journal-title":"Radiologia Medica"},{"issue":"13","key":"10.1002\/14651858.CD011649.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.ejca.2013.05.011","article-title":"A randomised phase II study of TSU-68 in patients with hepatocellular carcinoma treated by transarterial chemoembolisation","volume":"49","author":"Inaba","year":"2013","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"ix243","DOI":"10.1016\/S0923-7534(20)33312-3","article-title":"Final results of a randomized phase II study of TSU-68 after transarterial chemoembolisation in Japanese patients with unresectable hepatocellular carcinoma","volume":"23","author":"Kaneko","year":"2012","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/liv.12750","article-title":"Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma","volume":"35","author":"Kolligs","year":"2015","journal-title":"Liver International"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0037|cit37","first-page":"693A","article-title":"Radiofrequency ablation therapy combined with or without subsegmental lipiodol TAE for large hepatocellular carcinoma: a randomized prospective study","volume":"36","author":"Kudo","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hep.27290","article-title":"Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized phase III trial","volume":"60","author":"Kudo","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"11","key":"10.1002\/14651858.CD011649.pub2-BIB0040|cit40","first-page":"754","article-title":"Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma","volume":"89","author":"Li","year":"2009","journal-title":"National Medical Journal of China"},{"issue":"13","key":"10.1002\/14651858.CD011649.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.ejca.2010.06.015","article-title":"Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma","volume":"46","author":"Li","year":"2010","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/02656731003717574","article-title":"Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma","volume":"26","author":"Liu","year":"2010","journal-title":"International Journal of Hyperthermia"},{"issue":"7-8","key":"10.1002\/14651858.CD011649.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3727\/096504005776449716","article-title":"Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial","volume":"15","author":"Livraghi","year":"2005","journal-title":"Oncology Research"},{"issue":"9319","key":"10.1002\/14651858.CD011649.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD011649.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1359-6349(07)71010-8","article-title":"Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma","volume":"5","author":"Llovet","year":"2007","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00270-009-9750-0","article-title":"Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with beadblock for hepatocellular carcinoma","volume":"33","author":"Malagari","year":"2010","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"Abstract: 4018","DOI":"10.1200\/JCO.2016.34.15_suppl.4018","article-title":"TACE 2: a randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC)","volume":"34","author":"Meyer","year":"2016","journal-title":"Journal of Clinical Oncology Conference"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0168-8278(13)60115-4","article-title":"A prospective randomized trial comparing HDR-brachytherapy and transarterial chemoembolization in hepatocellular carcinoma","volume":"58","author":"Mohnike","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"23","key":"10.1002\/14651858.CD011649.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1002\/cncr.25314","article-title":"Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization","volume":"116","author":"Morimoto","year":"2010","journal-title":"Cancer"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD011649.pub2-BIB0051|cit51","first-page":"1366A","article-title":"Long-term outcome in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial to determine the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization","volume":"54","author":"Morimoto","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10637-011-9776-4","article-title":"A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (miriplatin) for hepatocellular carcinoma","volume":"30","author":"Okusaka","year":"2012","journal-title":"Investigational New Drugs"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jvir.2012.11.023","article-title":"Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles","volume":"24","author":"Padia","year":"2013","journal-title":"Journal of Vascular & Interventional Radiology"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC","volume":"29","author":"Pelletier","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1634\/theoncologist.2011-0313","article-title":"Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial","volume":"17","author":"Sansonno","year":"2012","journal-title":"Oncologist"},{"issue":"11","key":"10.1002\/14651858.CD011649.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/00042737-199411000-00005","article-title":"Improved survival with percutaneous ethanol injection in patients with large hepatocellular carcinoma","volume":"6","author":"Sarin","year":"1994","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0057|cit57","first-page":"9","article-title":"Prospective randomized controlled study of transarterial chemoembolization with doxorubicin versus doxorubicin\/lobaplatin\/mitomycin combination for unresectable hepatocellular carcinoma","volume":"36","author":"Shi","year":"2009","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/hepr.12100","article-title":"Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma","volume":"44","author":"Tanaka","year":"2014","journal-title":"Hepatology Research"},{"issue":"12","key":"10.1002\/14651858.CD011649.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3724\/SP.J.1008.2009.01379","article-title":"Effect of preoperative transcatheter arterial chemoembolization for treatment of resectable large hepatocellular carcinoma: a clinical randomized controlled trial","volume":"30","author":"Tang","year":"2009","journal-title":"Academic Journal of Second Military Medical University"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0060|cit60","first-page":"1159A","article-title":"AVATACE-1 trial: bevacizumab as inhibitor of collateral tumor-vessel-growth during transarterial chemoembolisation (TACE) for hepatocellular carcinoma - a double-blind, randomized, placebo-controlled pilot-trial","volume":"52","author":"Ulbrich","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S0168-8278(10)60123-7","article-title":"Interim safety-analysis of the AVATACE-1 trial (bevacizumab as inhibitor of collateral tumor-vessel-growth during transarterial chemoembolisation (TACE) for hepatocellular carcinoma - a double-blind randomized placebo-controlled pilot-trial","volume":"52","author":"Ulbrich","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11136-006-9133-9","article-title":"Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone","volume":"16","author":"Wang","year":"2007","journal-title":"Quality of Life Research"},{"issue":"20","key":"10.1002\/14651858.CD011649.pub2-BIB0063|cit63","first-page":"1617","article-title":"Clinical study of TACE with or without antiviral treatment for hepatitis B virus related unresectable hepatocellular carcinoma","volume":"21","author":"Wang","year":"2014","journal-title":"Chinese Journal of Cancer Prevention and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/bjs.1800820141","article-title":"Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal","volume":"82","author":"Wu","year":"1995","journal-title":"British Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0065|cit65","first-page":"391","article-title":"Transcatheter arterial chemo-embolization combined with CT-guided percutaneous intratumoral injection of lipiodol-ethanol for the treatment of primary hepatocellular carcinoma","volume":"20","author":"Wu","year":"1998","journal-title":"Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]"},{"issue":"10","key":"10.1002\/14651858.CD011649.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.7314\/APJCP.2015.16.10.4451","article-title":"Health-related quality of life of patients with intermediate hepatocellular carcinoma after liver resection or transcatheter arterial chemoembolization","volume":"16","author":"Xie","year":"2015","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"29","key":"10.1002\/14651858.CD011649.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.3748\/wjg.15.3664","article-title":"Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma","volume":"15","author":"Xu","year":"2009","journal-title":"World Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011649.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12325-008-0079-x","article-title":"Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC","volume":"25","author":"Yang","year":"2008","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0069|cit69","first-page":"21","article-title":"A prospective RCT comparing partial hepatectomy with TACE for multinodular HCC outside of Milan criteria","volume":"15","author":"Yin","year":"2013","journal-title":"HPB : the Official Journal of the International Hepato Pancreato Biliary Association"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s10637-011-9726-1","article-title":"Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study","volume":"29","author":"Zhang","year":"2011","journal-title":"Investigational New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/SLA.0b013e3181961c16","article-title":"A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma","volume":"249","author":"Zhou","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0072|cit72","unstructured":"Lee KG Kyung T A study of MG4101 (allogeneic natural killer cell) for intermediate-stage of hepatocellular carcinoma clinicaltrials.gov\/ct2\/show\/NCT02854839"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1745-6215-13-144","article-title":"Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (trace): study protocol for a randomized controlled trial","volume":"13","author":"Seinstra","year":"2012","journal-title":"Trials"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD011649.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.jvir.2011.12.496","article-title":"Transarterial radioembolization versus chemoembolization for the treatment of HCC: trace trial-an international multicenter randomized controlled trial","volume":"23","author":"Seinstra","year":"2012","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1245\/s10434-013-3211-3","article-title":"Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis","volume":"21","author":"Arnaoutakis","year":"2014","journal-title":"Annals of Surgical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.suc.2013.08.008","article-title":"Management of hepatocellular carcinoma","volume":"93","author":"Asham","year":"2013","journal-title":"Surgical Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best Practice & Research: Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD011649.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/SLA.0b013e3182822c02","article-title":"Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma","volume":"257","author":"Chan","year":"2013","journal-title":"Annals of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"Spirit 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Tetzlaff","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"14","key":"10.1002\/14651858.CD011649.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ejca.2012.02.063","article-title":"Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies","volume":"48","author":"Chen","year":"2012","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","article-title":"Prospective validation of the Barcelona Clinic Liver Cancer staging system","volume":"44","author":"Cillo","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators","volume":"28","author":"The cancer of the liver Italian program (CLIP) investigators","year":"1998","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2004.07.020","article-title":"Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study","volume":"127","author":"Davila","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"e63509","DOI":"10.1371\/journal.pone.0063509","article-title":"Efficacy of new generation antidepressants: differences seem illusory","volume":"8","author":"Del Re","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7-8","key":"10.1002\/14651858.CD011649.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0091|cit91","unstructured":"Dias S Sutton AJ Welton NJ Ades AE NICE DSU Technical Support Document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment, September 2011 (last updated April 2012) www.nicedsu.org.uk\/TSD3%20Heterogeneity.final%20report.08.05.12.pdf"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0092|cit92","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU Technical Support Document 1: introduction to evidence synthesis for decision making, April 2011 (last updated April 2012) www.nicedsu.org.uk\/TSD1%20Introduction.final.08.05.12.pdf"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0093|cit93","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU Technical Support Document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, August 2011 (last updated April 2014) www.nicedsu.org.uk\/TSD2%20General%20meta%20analysis%20corrected%2015April2014.pdf"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0094|cit94","unstructured":"Dias S Welton NJ Sutton AJ Caldwell DM Lu G Ades AE NICE DSU Technical Support Document 4: inconsistency in networks of evidence based on randomised controlled trials, May 2011 (last updated April 2014) www.nicedsu.org.uk\/TSD4%20Inconsistency.final.15April2014.pdf"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for Study of Liver","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD011649.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0097|cit97","unstructured":"About EQ-5D, 2014 www.euroqol.org\/about-eq-5d.html"},{"issue":"9","key":"10.1002\/14651858.CD011649.pub2-BIB0098|cit98","first-page":"525","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nature Reviews: Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.2214\/AJR.13.11511","article-title":"Hepatocellular carcinoma in the noncirrhotic liver","volume":"203","author":"Gaddikeri","year":"2014","journal-title":"American Journal of Roentgenology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.12.004","article-title":"Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis","volume":"52","author":"Germani","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011649.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/lt.22336","article-title":"Which matters most: number of tumors, size of the largest tumor, or total tumor volume?","volume":"17","author":"Germani","year":"2011","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0102|cit102","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary Group About Cochrane (Cochrane Review Groups (CRGs)) 2016, Issue 10. Art. No.: LIVER"},{"issue":"24","key":"10.1002\/14651858.CD011649.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.3748\/wjg.v20.i24.7525","article-title":"Hepatocellular carcinoma: surgical perspectives beyond the Barcelona Clinic Liver Cancer recommendations","volume":"20","author":"Guglielmi","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006660.pub3","article-title":"Methods of preventing bacterial sepsis and wound complications after liver transplantation","author":"Gurusamy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD011649.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1053\/j.gastro.2004.09.031","article-title":"Thermal ablation for hepatocellular carcinoma","volume":"127","author":"Head","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13651820310015833","article-title":"AHPBA\/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement","volume":"5","author":"Henderson","year":"2003","journal-title":"HPB : the Official Journal of the International Hepato Pancreato Biliary Association"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0108|cit108","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD011649.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ejrad.2014.06.031","article-title":"Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma","volume":"83","author":"Hoffmann","year":"2014","journal-title":"European Journal of Radiology"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0111|cit111","unstructured":"International Agency for Research on Cancer GLOBOCAN 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012. Liver cancer estimated incidence, mortality and prevalence worldwide in 2012 globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0112|cit112","unstructured":"International Agency for Research on Cancer World 2012 (estimated cancer incidence, all ages: both sexes) globocan.iarc.fr\/old\/summary_table_pop-html.asp?selection=224900&title=World&sex=0&type=0&window=1&sort=0&submit=%C2%A0Execute"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0113|cit113","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"7","key":"10.1002\/14651858.CD011649.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ijc.22860","article-title":"Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends","volume":"121","author":"Jepsen","year":"2007","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/M14-0558","article-title":"Screening for hepatocellular carcinoma in chronic liver disease: a systematic review","volume":"161","author":"Kansagara","year":"2014","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011649.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.seminoncol.2014.09.022","article-title":"Stereotactic body radiotherapy","volume":"41","author":"Kollar","year":"2014","journal-title":"Seminars in Oncology"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3748\/wjg.v20.i6.1544","article-title":"Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations","volume":"20","author":"Ladep","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyp280","article-title":"Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer","volume":"38","author":"Lee","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0033-1333648","article-title":"Chemoembolization of hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2013","journal-title":"Seminars in Interventional Radiology"},{"issue":"14","key":"10.1002\/14651858.CD011649.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","article-title":"Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis","volume":"48","author":"Liu","year":"2012","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Seminars in Liver Disease"},{"issue":"9399","key":"10.1002\/14651858.CD011649.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"issue":"474","key":"10.1002\/14651858.CD011649.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2007.03.015","article-title":"Oral contraception and the risk of hepatocellular carcinoma","volume":"47","author":"Maheshwari","year":"2007","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011650.pub2","article-title":"Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysis","author":"Majumdar","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011649.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0033-1333653","article-title":"Radiofrequency ablation of liver tumors","volume":"30","author":"McDermott","year":"2013","journal-title":"Seminars in Interventional Radiology"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1536867X1301300106","article-title":"Trial sequential boundaries for cumulative meta-analyses","volume":"13","author":"Miladinovic","year":"2013","journal-title":"Stata Journal"},{"issue":"12","key":"10.1002\/14651858.CD011649.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"issue":"9128","key":"10.1002\/14651858.CD011649.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00535-005-1751-4","article-title":"Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy","volume":"41","author":"Nanashima","year":"2006","journal-title":"Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0136|cit136","unstructured":"Carcinoma, hepatocellular, 2014 www.ncbi.nlm.nih.gov\/mesh\/68006528"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/21.5.837","article-title":"Intention-to-treat analysis: implications for quantitative and qualitative research","volume":"21","author":"Newell","year":"1992","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/SLA.0b013e3181b0c4df","article-title":"World review of laparoscopic liver resection - 2,804 patients","volume":"250","author":"Nguyen","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0139|cit139","unstructured":"NHS Blood and Transplant Organ donation. Activity report 2013-2014 www.organdonation.nhs.uk\/statistics\/transplant_activity_report\/"},{"issue":"49","key":"10.1002\/14651858.CD011649.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"e5591","DOI":"10.1097\/MD.0000000000005591","article-title":"Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC","volume":"95","author":"Niu","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004787.pub2","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0143|cit143","unstructured":"Members of OpenBUGS Project Management Group OpenBUGS 2014"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0144|cit144","unstructured":"Organ Procurement and Transplantation Network Policies, 2014 optn.transplant.hrsa.gov\/ContentDocuments\/OPTN_Policies.pdf"},{"issue":"10","key":"10.1002\/14651858.CD011649.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1586\/14737140.8.10.1623","article-title":"TACE versus TAE as therapy for hepatocellular carcinoma","volume":"8","author":"Pleguezuelo","year":"2008","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"9","key":"10.1002\/14651858.CD011649.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1478-3231.2008.01704.x","article-title":"Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis","volume":"28","author":"Pocobelli","year":"2008","journal-title":"Liver International"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdn565","article-title":"The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma","volume":"20","author":"Polesel","year":"2009","journal-title":"Annals of Oncology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011649.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/lt.22380","article-title":"Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement","volume":"17","author":"Prasad","year":"2011","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0149|cit149","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0150|cit150","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-13-34","article-title":"Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis","volume":"13","author":"Sang","year":"2013","journal-title":"BMC Gastroenterology"},{"issue":"35","key":"10.1002\/14651858.CD011649.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD011649.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011649.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2517-6161.1993.tb01921.x","article-title":"Bayesian interval estimates which are also confidence intervals","volume":"55","author":"Severini","year":"1993","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.suc.2010.04.014","article-title":"Hepatic tumor ablation","volume":"90","author":"Sindram","year":"2010","journal-title":"Surgical Clinics of North America"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0161|cit161","doi-asserted-by":"crossref","unstructured":"OPTN\/SRTR 2012 annual data report: liver srtr.transplant.hrsa.gov\/annual_reports\/2012\/pdf\/03_liver_13.pdf","DOI":"10.1111\/ajt.12026"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0163|cit163","unstructured":"Stata\/SE 14.2 for Windows[64-bit x86-64] StataCorp LP 2017"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0164|cit164","first-page":"223","article-title":"Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan","volume":"21","author":"Taura","year":"2009","journal-title":"Oncology Reports"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0165|cit165","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2046-4053-1-41","article-title":"Sample size and power considerations in network meta-analysis","volume":"1","author":"Thorlund","year":"2012","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0167|cit167","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"12","key":"10.1002\/14651858.CD011649.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3748\/wjg.v20.i12.3069","article-title":"Transarterial chemoembolization and bland embolization for hepatocellular carcinoma","volume":"20","author":"Tsochatzis","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.24794","article-title":"Family history of liver cancer and hepatocellular carcinoma","volume":"55","author":"Turati","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"8","key":"10.1002\/14651858.CD011649.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","article-title":"Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Turati","year":"2014","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011649.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1586\/14737159.5.3.377","article-title":"Staging classifications for hepatocellular carcinoma","volume":"5","author":"Van Deusen","year":"2005","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"12","key":"10.1002\/14651858.CD011649.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.ejca.2011.04.027","article-title":"Molecular classification of hepatocellular carcinoma anno 2011","volume":"47","author":"Van Malenstein","year":"2011","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"Valkenhoef","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"9","key":"10.1002\/14651858.CD011649.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3109\/00365521.2011.589472","article-title":"Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany","volume":"46","author":"Von Hahn","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/lt.23836","article-title":"Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis","volume":"20","author":"Wan","year":"2014","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD011649.pub2-BIB0177|cit177","unstructured":"Ware JE SF-36\u00ae health survey update, 2014 www.sf-36.org\/tools\/sf36.shtml"},{"issue":"1","key":"10.1002\/14651858.CD011649.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0179|cit179","first-page":"450","article-title":"Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival","volume":"24","author":"Witjes","year":"2012","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"7644","key":"10.1002\/14651858.CD011649.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD011649.pub2-BIB0181|cit181","first-page":"1167","article-title":"Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications","volume":"149","author":"Wu","year":"1996","journal-title":"American Journal of Pathology"},{"issue":"45","key":"10.1002\/14651858.CD011649.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.3748\/wjg.v18.i45.6657","article-title":"Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma","volume":"18","author":"Xiong","year":"2012","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011649.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2014.08.005","article-title":"Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis","volume":"147","author":"Yang","year":"2014","journal-title":"Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011649.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T16:56:05Z","timestamp":1658768165000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011649.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":183,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011649.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}